• Committee Members
• Author Information
• Acknowledgment of Support
• Key Words
• Abstract
• Committee Disclosure

Administrative support provided by the Heart Failure Society of America.

The Guideline Committee would like to thank the Executive Council for their review and comments and the following individuals for their input in revising specific sections;

Jonathan G. Howlett (University of Calgary) and Richard J. Rodeheffer (Mayo Clinic & Foundation), Prevention Section; Marvin W. Kronenberg (Vanderbilt University), Nonpharmacologic Management and HF with Preserved LVEF Sections; Alan B. Miller (University of Florida, Jacksonville), Drug Therapy Section; Sarah J. Goodlin (Patient Centered Research and Education, Salt Lake City, Utah), Disease Management, Advance Directives, and End-of-Life Care in Heart Failure Section; Kenneth L. Baughman (deceased, Brigham & Women’s Hospital, Boston, Massachusetts), Myocarditis Section; Michael R. Zile, MD, HF With Preserved LVEF Section; Bart Galle, PhD and Wendy Gattis Stough, PharmD for their scientific and editorial contributions; and Cheryl Yano for administrative support.